Home/Pipeline/Undisclosed Male Fertility Diagnostic

Undisclosed Male Fertility Diagnostic

Male Fertility Assessment

Research/DevelopmentActive

Key Facts

Indication
Male Fertility Assessment
Phase
Research/Development
Status
Active
Company

About Arex Life Sciences

Arex Life Sciences is a nascent biotech firm operating in the male fertility diagnostics sector. The company, established in 2020 and headquartered in Watertown, MA (Boston area), is actively engaged in scientific research, as evidenced by its participation and poster presentations at major andrology conferences like the American Society of Andrology (ASA) and the American Society for Reproductive Medicine (ASRM). With no detailed public information on its technology or pipeline, the company is positioned in a high-need but competitive segment of reproductive health, likely seeking to validate and commercialize its diagnostic approach.

View full company profile

Other Male Fertility Assessment Drugs

DrugCompanyPhase
RoXsta™ Oxidative Stress DiagnosticMemphasysPhase 2
AI Semen Analysisillumicell AIDevelopment